Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00377052
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2006-09-13
Brief Title:
Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent mantle cell lymphoma | View |